Clinical trials
Enrolling by invitation Observational Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Allogene Therapeutics | 1 |
| Audubon Bioscience | 1 |
| AvenCell Therapeutics, Inc. | 1 |
| CRISPR Therapeutics AG | 1 |
| Caribou Biosciences, Inc. | 1 |
| Kite, A Gilead Company | 1 |
| Sofia Ramström | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 13 |
| Autoimmune Diseases | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, B-Cell | 2 |
| Multiple Myeloma | 2 |
| Neoplasms | 2 |
| Thrombocytopenia | 2 |
| Anemia | 1 |
| Cardiovascular Diseases | 1 |
| Communicable Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.